Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

937 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Fosamprenavir (GW433908)/ritonavir in HIV-infected patients: efficacy and safety results from the Spanish Expanded Access Program.
Pérez-Elias MJ, Sánchez-Conde M, Soriano V, Mallolas J, Luque I, Rodríguez-Alcántara F; Fosamprenavir Expanded Access Program Group. Pérez-Elias MJ, et al. Enferm Infecc Microbiol Clin. 2009 Jan;27(1):28-32. doi: 10.1016/j.eimc.2008.05.002. Epub 2009 Jan 9. Enferm Infecc Microbiol Clin. 2009. PMID: 19218000 Clinical Trial.
Etravirine resistance associated mutations in HIV-infected patients failing efavirenz or nevirapine in the Spanish antiretroviral resistance database.
Poveda E, Anta L, Blanco JL, Pérez-Elías MJ, García F, Leal M, Ribera E, Gutiérrez F, Soriano V, de Mendoza C; Resistance Platform of the Spanish AIDS Research Network (ResRIS). Poveda E, et al. Among authors: gutierrez f. AIDS. 2010 Jan 28;24(3):469-71. doi: 10.1097/QAD.0b013e328331a4b8. AIDS. 2010. PMID: 20057310
Drug resistance mutations in HIV-infected patients in the Spanish drug resistance database failing tipranavir and darunavir therapy.
Poveda E, Anta L, Blanco JL, Casado JL, Gutiérrez F, García F, Gómez-Sirvent JL, Iribarren JA, Soriano V, de Mendoza C; Resistance Platform of the Spanish AIDS Research Network (ResRIS). Poveda E, et al. Among authors: gutierrez f. Antimicrob Agents Chemother. 2010 Jul;54(7):3018-20. doi: 10.1128/AAC.00160-10. Epub 2010 May 17. Antimicrob Agents Chemother. 2010. PMID: 20479204 Free PMC article.
A highly sensitive and specific model for predicting HIV-1 tropism in treatment-experienced patients combining interpretation of V3 loop sequences and clinical parameters.
Sánchez V, Masiá M, Robledano C, Padilla S, Lumbreras B, Poveda E, De Mendoza C, Soriano V, Gutiérrez F. Sánchez V, et al. Among authors: gutierrez f. J Acquir Immune Defic Syndr. 2011 Jan 1;56(1):51-8. doi: 10.1097/QAI.0b013e3181fc012b. J Acquir Immune Defic Syndr. 2011. PMID: 21068675
Most HIV type 1 non-B infections in the Spanish cohort of antiretroviral treatment-naïve HIV-infected patients (CoRIS) are due to recombinant viruses.
Yebra G, de Mulder M, Martín L, Rodríguez C, Labarga P, Viciana I, Berenguer J, Alemán MR, Pineda JA, García F, Holguín A; Cohort of the Spanish AIDS Research Network (CoRIS). Yebra G, et al. J Clin Microbiol. 2012 Feb;50(2):407-13. doi: 10.1128/JCM.05798-11. Epub 2011 Dec 7. J Clin Microbiol. 2012. PMID: 22162552 Free PMC article.
Evolution of HIV-1 genotype in plasma RNA and peripheral blood mononuclear cells proviral DNA after interruption and resumption of antiretroviral therapy.
Imaz A, Olmo M, Peñaranda M, Gutiérrez F, Romeu J, Larrousse M, Domingo P, Oteo JA, Niubó J, Curto J, Vilallonga C, Masiá M, López-Aldeguer J, Iribarren JA, Podzamczer D; STOPAR Study Team. Imaz A, et al. Among authors: gutierrez f. Antivir Ther. 2012;17(3):577-83. doi: 10.3851/IMP2025. Epub 2011 Dec 19. Antivir Ther. 2012. PMID: 22301439 Clinical Trial.
937 results